Education
About Us
Working with TipRanks
Follow Us
Aridis Pharmaceuticals (ARDS)
OTHER OTC:ARDS
| Dec 22 | Dec 21 | Dec 20 | Dec 19 | Dec 18 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 1.00M | $ 1.02M | $ 2.76M |
| Gross Profit | $ 0.00 | $ 0.00 | $ 1.00M | $ 1.02M | $ 2.76M |
| Operating Income | $ -29.99M | $ -43.71M | $ -22.40M | $ -29.09M | $ -24.12M |
| EBITDA | $ -29.51M | $ -44.43M | $ -22.06M | $ -28.75M | $ -23.83M |
| Net Income | $ -30.75M | $ -42.28M | $ -22.33M | $ -29.68M | $ -22.11M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 4.88M | $ 19.99M | $ 8.23M | $ 20.90M | $ 24.24M |
| Total Assets | $ 14.70M | $ 26.80M | $ 15.12M | $ 27.97M | $ 31.61M |
| Total Debt | $ 6.13M | $ 5.98M | $ 715.00K | $ 0.00 | $ 0.00 |
| Net Debt | $ 1.25M | $ -14.01M | $ -7.52M | $ -20.90M | $ -24.24M |
| Total Liabilities | $ 38.93M | $ 40.91M | $ 23.80M | $ 24.33M | $ 5.30M |
| Stockholders' Equity | $ -24.23M | $ -13.11M | $ -8.68M | $ 3.64M | $ 26.31M |
| Cash Flow | |||||
| Free Cash Flow | $ -29.21M | $ -23.47M | $ -20.84M | $ -8.33M | $ -24.95M |
| Operating Cash Flow | $ -29.13M | $ -22.94M | $ -20.48M | $ -8.16M | $ -24.27M |
| Investing Cash Flow | $ -82.00K | $ -530.00K | $ -367.00K | $ -174.00K | $ -1.68M |
| Financing Cash Flow | $ 14.78M | $ 34.72M | $ 8.68M | $ 4.99M | $ 25.09M |
Aridis Pharmaceuticals Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.